From: Impact of antigen avoidance test for fibrotic hypersensitivity pneumonitis in stable phase
Variables | Level | Univariate p | Multivariate | ||
---|---|---|---|---|---|
HR | 95% CI | p | |||
Age | 0.169 | ||||
Smoking history | Never vs. Former and current | 0.263 | |||
Serum Krebs von den Lungen-6 (U/mL) | ≥ 1630 vs. < 1630 | 0.678 | |||
Forced vital capacity (%) | ≥ 80 vs. < 80 | 0.137 | 0.46 | 0.153–1.41 | 0.174 |
Lymphocytes in BAL (%) | ≥ 30 vs. < 30 | 0.218 | |||
Airway-centered fibrosis | 0.370 | ||||
Lymphocyte-predominant Bronchiolitis | 0.615 | ||||
Poorly formed granulomas | 0.338 | ||||
Fibroblastic foci | 0.210 | ||||
Organizing pneumonia | 0.109 | 6.49 | 0.75–56.0 | 0.089 | |
Antigen avoidance test | Positive vs. Negative | 0.081 | 0.26 | 0.07–0.90 | 0.034 |